Pressure-relief eye tech advances toward approval

Elie Dolgin • March 22, 2024

FDA panel’s green light on glaucoma wearable device offers hope in sight.

On March 21, an advisory panel to the U.S. Food and Drug Administration (FDA) gave its unanimous blessing to a piece of wearable technology that alleviates symptoms of the progressive eye disease glaucoma.

Known as the FSYX Ocular Pressure Adjusting Pump (OPAP) system, the device is designed to ease the pressure that accumulates in the eyes of people with glaucoma. This elevated pressure poses a risk of damaging the optic nerve that relays visual information to the brain, leading to irreversible vision loss.

“This will give our toughest-to-treat patients additional options,” says John Berdahl, an ophthalmologist in Sioux Falls, S.D., and the founder of Balance Ophthalmics, the company developing the OPAP system.


Continue reading at IEEE Spectrum.

‘Connectoids’ use microfluid channels to recapitulate and study neural connections.
By Elie Dolgin May 14, 2025
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Picture of scientist handling mRNA, Robert F. Kennedy Jr. and vaccine protesters.
By Elie Dolgin May 9, 2025
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.